ClearNote Health

Clear Note Health

Biotechnology, Science Center Dr, San Diego, , 92121, California, 10578, United States, 11-50 Employees

bluestargenomics.com

  • facebook
  • LinkedIn

Who is CLEARNOTE HEALTH

ClearNote Health Cancer detection company enabling people at risk for high-mortality cancers to live longer, healthier lives. We focus on developing non-invasive tests to detect cancer th...

Read More

map
  • 10578 Science Center Dr, San Diego, California, 92121, United States Headquarters: 10578 Science Center Dr, San Diego, California, 92121, United States
  • 2016 Date Founded: 2016
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from CLEARNOTE HEALTH

ClearNote Health Org Chart and Mapping

Employees

Melissa P

Director, Clinical Research Repository

Maryam Nabiyouni

Lead Automation Scientist

Yuhong Ning

Distinguished Computational Biologist

Wayne Volkmuth

SVP, Informatics and Data Discovery

Yuan Xue

Bioinformatics Scientist II

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding ClearNote Health

Answer: ClearNote Health's headquarters are located at Science Center Dr, San Diego, , 92121, California, 10578, United States

Answer: ClearNote Health's official website is https://bluestargenomics.com

Answer: ClearNote Health's revenue is $10 Million to $25 Million

Answer: ClearNote Health's SIC: 2834

Answer: ClearNote Health's NAICS: 325412

Answer: ClearNote Health has 11-50 employees

Answer: ClearNote Health is in Biotechnology

Answer: ClearNote Health contact info: Phone number: Website: https://bluestargenomics.com

Answer: ClearNote Health Cancer detection company enabling people at risk for high-mortality cancers to live longer, healthier lives. We focus on developing non-invasive tests to detect cancer through a standard blood draw earlier than existing methods by harnessing the power of epigenomics. We apply our proprietary epigenomic platform, combining biology and artificial intelligence, to identify DNA-based changes in biology as cancer develops. With lead programs in non-invasive early detection of pancreatic and ovarian cancers in patients at the highest risk for these diseases. Headquartered in the U.S, the companys CLIA and CAP-accredited laboratory is located in San Diego, Calif., with additional presence in the San Francisco Bay Area and internationally. #biotechnology #epigenomics #oncology #cancerresearch #cancer

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access